0
     

Report Added
Report already added
Global Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026

Global Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026

Summary

Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The global biotechnology market had total revenues of $743.3 billion in 2021, representing a compound annual growth rate (CAGR) of 13.5% between 2016 and 2021.
- The medical/healthcare segment generated the most revenue in 2021, with total revenues of $422.1 billion, equivalent to 56.8% of the market's overall value.
- The US market is by far the largest globally, accounting for 38.7% of its total value in 2021. Comparatively, the entire Asia-Pacific and European regions accounted for 33.6% and 21.3% of the global market’s value respectively.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the global
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global biotechnology market
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Global biotechnology market with five year forecasts

Reasons to Buy

- What was the size of the Global biotechnology market by value in 2021?
- What will be the size of the Global biotechnology market in 2026?
- What factors are affecting the strength of competition in the Global biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up the global's biotechnology market?

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent M&A activity?
8 Company Profiles
8.1. Johnson & Johnson
8.2. F. Hoffmann-La Roche Ltd
8.3. BioNTech SE
8.4. Bayer AG
8.5. Novartis AG
8.6. Takeda Pharmaceutical Company Limited
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: Global biotechnology industry value: $ billion, 2016–21
Table 2: Global biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: Global biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Global biotechnology industry geography segmentation: $ billion, 2021
Table 5: Global biotechnology industry value forecast: $ billion, 2021–26
Table 6: Johnson & Johnson: key facts
Table 7: Johnson & Johnson: Annual Financial Ratios
Table 8: Johnson & Johnson: Key Employees
Table 9: Johnson & Johnson: Key Employees Continued
Table 10: F. Hoffmann-La Roche Ltd: key facts
Table 11: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 12: F. Hoffmann-La Roche Ltd: Key Employees
Table 13: BioNTech SE: key facts
Table 14: BioNTech SE: Annual Financial Ratios
Table 15: BioNTech SE: Key Employees
Table 16: Bayer AG: key facts
Table 17: Bayer AG: Annual Financial Ratios
Table 18: Bayer AG: Key Employees
Table 19: Bayer AG: Key Employees Continued
Table 20: Novartis AG: key facts
Table 21: Novartis AG: Annual Financial Ratios
Table 22: Novartis AG: Key Employees
Table 23: Novartis AG: Key Employees Continued
Table 24: Takeda Pharmaceutical Company Limited: key facts
Table 25: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 26: Takeda Pharmaceutical Company Limited: Key Employees
Table 27: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 28: Global exchange rate, 2017–21

List of Figures
Figure 1: Global biotechnology industry value: $ billion, 2016–21
Figure 2: Global biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Global biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Global biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the global biotechnology industry, 2021
Figure 6: Drivers of buyer power in the global biotechnology industry, 2021
Figure 7: Drivers of supplier power in the global biotechnology industry, 2021
Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2021
Figure 9: Factors influencing the threat of substitutes in the global biotechnology industry, 2021
Figure 10: Drivers of degree of rivalry in the global biotechnology industry, 2021

Report Title: Global Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW